ANAHITA SABBAR: Open Payments
NPI 1760752596 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 27 payments from 12 companies in 2025. Trend: 2023 $187 · 2024 $327 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $141 |
| AstraZeneca Pharmaceuticals LP | 5 | $106 |
| Amgen Inc. | 4 | $90 |
| Novo Nordisk Inc | 3 | $64 |
| Lilly USA, LLC | 2 | $55 |
| Bausch Health US, LLC | 2 | $49 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| Intra-Sana Laboratories | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: Kerendia, MOUNJARO, APLENZIN, OTEZLA, Ozempic, AIRSUPRA, SHINGRIX, EVENITY.
Industry payments across CA — which companies pay providers there.
